143 related articles for article (PubMed ID: 7851835)
1. [Severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C associated with systemic lupus erythematosus].
Kimura Y; Kajiyama K; Nomura H; Shiraishi G
Fukuoka Igaku Zasshi; 1994 Nov; 85(11):329-33. PubMed ID: 7851835
[TBL] [Abstract][Full Text] [Related]
2. Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection.
Shrestha R; McKinley C; Bilir BM; Everson GT
Am J Gastroenterol; 1995 Jul; 90(7):1146-7. PubMed ID: 7611214
[TBL] [Abstract][Full Text] [Related]
3. [Autoimmune hemolytic anemia reactivated by alpha-interferon therapy in a case of chronic active C-type hepatitis].
Katayama T; Naitou Y; Kusaka M; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Kobayashi M
Rinsho Ketsueki; 1995 Apr; 36(4):339-46. PubMed ID: 7783339
[TBL] [Abstract][Full Text] [Related]
4. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C.
Fujii H; Kitada T; Yamada T; Sakaguchi H; Seki S; Hino M
Hepatogastroenterology; 2003; 50(51):841-2. PubMed ID: 12828100
[TBL] [Abstract][Full Text] [Related]
5. [A case of allograft rejection induced by the interferon-alpha therapy to hepatitis type C after renal transplantation].
Kakimoto K; Takahara S; Kokado Y; Kameoka H; Ishibashi M; Okuyama A; Kyo M; Nagano S
Hinyokika Kiyo; 1994 Jun; 40(6):529-32. PubMed ID: 8073963
[TBL] [Abstract][Full Text] [Related]
6. [Anti-platelet antibody and severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C].
Tanaka Y; Hayashida K; Ikematsu W; Umeno M; Ishibashi H; Niho Y
Nihon Rinsho Meneki Gakkai Kaishi; 1996 Apr; 19(2):150-6. PubMed ID: 8705692
[TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenia after alpha-interferon therapy in a patient with chronic hepatitis C.
López Morante AJ; Sáez-Royuela F; Casanova Valero F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
Am J Gastroenterol; 1992 Jun; 87(6):809-10. PubMed ID: 1590332
[No Abstract] [Full Text] [Related]
8. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
Fukushima T; Dong L; Sakai T; Sawaki T; Miki M; Tanaka M; Masaki Y; Hirose Y; Kuwana M; Umehara H
Lupus; 2008 Mar; 17(3):210-4. PubMed ID: 18372362
[TBL] [Abstract][Full Text] [Related]
9. Late marrow allograft rejection following alpha-interferon therapy for hepatitis in a patient with paroxysmal nocturnal hemoglobinuria.
de Souza MH; Abdelhay E; Silva ML; Diamond HR; Valente AN; Tabak DG; Bouzas LF; Ribeiro RC
Bone Marrow Transplant; 1992 Jun; 9(6):495-7. PubMed ID: 1628136
[TBL] [Abstract][Full Text] [Related]
10. [A case of systemic lupus erythematosus presenting with myelofibrosis as a cause of pancytopenia].
Fukuya H; Hirose W; Masuda T; Kawai T; Watanabe K; Kawagoe M
Ryumachi; 1994 Aug; 34(4):773-8. PubMed ID: 7974029
[TBL] [Abstract][Full Text] [Related]
11. Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia.
Iga D; Tomimatsu M; Endo H; Ohkawa S; Yamada O
Eur J Haematol; 2005 Nov; 75(5):417-23. PubMed ID: 16191092
[TBL] [Abstract][Full Text] [Related]
12. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
[TBL] [Abstract][Full Text] [Related]
13. [Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C].
Bacq Y; Sapey T; Gruel Y; Fimbel B; Degenne D; Barin F; Metman EH
Gastroenterol Clin Biol; 1996; 20(3):303-6. PubMed ID: 8763070
[TBL] [Abstract][Full Text] [Related]
14. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.
Wilson LE; Widman D; Dikman SH; Gorevic PD
Semin Arthritis Rheum; 2002 Dec; 32(3):163-73. PubMed ID: 12528081
[TBL] [Abstract][Full Text] [Related]
16. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
17. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
[TBL] [Abstract][Full Text] [Related]
18. Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.
Khan HA; Khawaja FI; Mahrous AR
Am J Gastroenterol; 1996 Apr; 91(4):821-2. PubMed ID: 8677971
[No Abstract] [Full Text] [Related]
19. Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial.
Simon DM; Gordon SC; Kaplan MM; Koff RS; Regenstein F; Everson G; Lee YM; Weiner F; Silverman A; Plasse T; Fedorczyk D; Liao MJ
Hepatology; 1997 Feb; 25(2):445-8. PubMed ID: 9021962
[TBL] [Abstract][Full Text] [Related]
20. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
